Danish experts now fear that more pharma companies will withdraw medicines from Denmark to avoid being penalised in the US market ...
Amgen (NASDAQ: AMGN) today announced that the Company will discuss the data supporting the Repatha TM (evolocumab) Biologics License Application (BLA) for the treatment of high cholesterol with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results